by Wendy Quinn, President of the Canadian Hemophilia Society This summer I had the great privilege of finally attending the infamous Camp Blast – the...
Montreal, August 15, 2022 – On July 15, Héma-Québec announced the results of the recombinant factor IX tender for the period from October 1, 2022...
In an effort to bring young volunteers into the CHS, and in recognition that a sound education is of utmost importance particularly for those who...
The highly popular and useful FactorFirst card has been revised and the new version is now available for orders! Thank you to a great team...
Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best...